These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32073020)

  • 1. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
    Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
    Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
    Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
    Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
    Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
    Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
    Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging microphysiological systems to address challenges encountered during development of oligonucleotide therapeutics.
    Ramsden D; Belair DG; Agarwal S; Andersson P; Humphreys S; Dalmas DA; Stahl SH; Maclauchlin C; Cichocki JA
    ALTEX; 2022; 39(2):273–296. PubMed ID: 34766620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance and potential roles of microphysiological systems in biology and medicine.
    Wikswo JP
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1061-72. PubMed ID: 25187571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
    Yamazaki D
    Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.
    Vernetti L; Gough A; Baetz N; Blutt S; Broughman JR; Brown JA; Foulke-Abel J; Hasan N; In J; Kelly E; Kovbasnjuk O; Repper J; Senutovitch N; Stabb J; Yeung C; Zachos NC; Donowitz M; Estes M; Himmelfarb J; Truskey G; Wikswo JP; Taylor DL
    Sci Rep; 2017 Feb; 7():42296. PubMed ID: 28176881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
    Kanamori T; Sugiura S; Sakai Y
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS).
    Malik M; Yang Y; Fathi P; Mahler GJ; Esch MB
    Front Cell Dev Biol; 2021; 9():721338. PubMed ID: 34568333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions.
    Bale SS; Borenstein JT
    Drug Metab Dispos; 2018 Nov; 46(11):1638-1646. PubMed ID: 30115643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on the Application of Microphysiological Systems to Drug Transporter Studies.
    Caetano-Pinto P; Stahl SH
    Drug Metab Dispos; 2018 Nov; 46(11):1647-1657. PubMed ID: 30135246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.